Wall St Price Targets

EC8 Price Targets Summary
Conmed Corp

Wall Street analysts forecast EC8 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EC8 is 32.45 EUR with a low forecast of 31.72 EUR and a high forecast of 33.82 EUR.

Lowest Forecast
Price Target
31.72 EUR
9% Downside
Average Forecast
Price Target
32.45 EUR
7% Downside
Highest Forecast
Price Target
33.82 EUR
3% Downside
Conmed Corp Competitors:
Price Targets
CBAN
Colony Bankcorp Inc
10% Upside
PAT
Panthera Resources PLC
329% Upside
ATC
Arctic Paper SA
70% Upside
7799
Heron Neutron Medical Corp
200% Upside

Revenue
Forecast

5% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
5% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.

Gross Profit
Forecast

5% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
5% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 7%.

Operating Income
Forecast

2% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
2% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 33%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
45% / Year
Estimated Growth
Estimates Accuracy
-40%
Average Miss
1% / Year
Past Growth
45% / Year
Estimated Growth
Estimates Accuracy
-40%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 45%.

Net Income
Forecast

1% / Year
Past Growth
52% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss
1% / Year
Past Growth
52% / Year
Estimated Growth
Estimates Accuracy
-36%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 52%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EC8's stock price target?
Price Target
32.45 EUR

According to Wall Street analysts, the average 1-year price target for EC8 is 32.45 EUR with a low forecast of 31.72 EUR and a high forecast of 33.82 EUR.

What is the Revenue forecast for Conmed Corp?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.

What is the Gross Profit forecast for Conmed Corp?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 7%.

What is the Operating Income forecast for Conmed Corp?
Projected CAGR
33%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 33%.

What is the Pre-Tax Income forecast for Conmed Corp?
Projected CAGR
45%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 45%.

What is the Net Income forecast for Conmed Corp?
Projected CAGR
52%

Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 52%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett